Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
D Bose, F Meric-Bernstam, W Hofstetter… - The lancet …, 2010 - thelancet.com
Vascular endothelial growth factor (VEGF) targeted therapy, either alone or in combination
with chemotherapy, has become the standard of care in several solid tumours, including …
with chemotherapy, has become the standard of care in several solid tumours, including …
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
D Bose, F Meric-Bernstam, W Hofstetter… - The Lancet …, 2010 - Elsevier
Vascular endothelial growth factor (VEGF) targeted therapy, either alone or in combination
with chemotherapy, has become the standard of care in several solid tumours, including …
with chemotherapy, has become the standard of care in several solid tumours, including …
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
D Bose, F Meric-Bernstam, W Hofstetter… - The Lancet …, 2010 - infona.pl
Vascular endothelial growth factor (VEGF) targeted therapy, either alone or in combination
with chemotherapy, has become the standard of care in several solid tumours, including …
with chemotherapy, has become the standard of care in several solid tumours, including …
[引用][C] Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
D BOSE - Lancet Oncol, 2010 - cir.nii.ac.jp
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications
for patient care | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
for patient care | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.
D Bose, F Meric-Bernstam, W Hofstetter… - The Lancet …, 2010 - europepmc.org
Vascular endothelial growth factor (VEGF) targeted therapy, either alone or in combination
with chemotherapy, has become the standard of care in several solid tumours, including …
with chemotherapy, has become the standard of care in several solid tumours, including …
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
D Bose, F Meric-Bernstam, W Hofstetter… - The Lancet …, 2010 - pubmed.ncbi.nlm.nih.gov
Vascular endothelial growth factor (VEGF) targeted therapy, either alone or in combination
with chemotherapy, has become the standard of care in several solid tumours, including …
with chemotherapy, has become the standard of care in several solid tumours, including …
Vascular endothelial growth factor targeted therapy in the perioperative setting: Implications for patient care
D Bose, F Meric-Bernstam… - The lancet …, 2010 - mdanderson.elsevierpure.com
Vascular endothelial growth factor (VEGF) targeted therapy, either alone or in combination
with chemotherapy, has become the standard of care in several solid tumours, including …
with chemotherapy, has become the standard of care in several solid tumours, including …
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
D Bose, F Meric-Bernstam, W Hofstetter… - The Lancet …, 2010 - thelancet.com
Vascular endothelial growth factor (VEGF) targeted therapy, either alone or in combination
with chemotherapy, has become the standard of care in several solid tumours, including …
with chemotherapy, has become the standard of care in several solid tumours, including …
[引用][C] Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care
D Bose, F Meric-Bernstam, W Hofstetter… - The Lancet …, 2010 - cir.nii.ac.jp
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications
for patient care | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …
for patient care | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データを …